Amarin Corp Plc (AMRN)

[KCSVEN]

Comparison:

Company 1:
2014 Sales estimate: 115 million (Range 70-177)
2014 Loss per share estimate: -.81
Current Ratio: 6.14

Company 2 :
2014 Sales estimate: 264 million (Range 161-605)
2014 Loss per share estimate: -.60
Current Ratio: 5.71

Company 1 Market Cap(ISIS): 2.82 billion
Company 2 Market Cap(AMRN): 900 million

Either ISIS is way over-valued or AMRN way Under valued or more likely somewhere in between.

I understand ISIS had a large pipeline and AMRN has 1 drug with multiple possible uses but a large pipeline also equals large costs for trials. There is no way ISIS is worth almost 3 times AMRN.

I'd say the BIG difference between the 2 is ISIS ability to partner with BP regularly which, to me, comes down to the whole reason the AMRN stock languishes, WS wants a BP partner, nobody has faith in a small company becoming a big company in Biotech without a partner.

Makes you wonder if AMRN should have looked to partner on day 1 of approval? I think they believe they could get a better deal waiting for Anchor, combo results etc.. as it takes uncertainty off the table, probably correct in that assessment so not sure what they could do differently to have reduced some of the haircut the stock price has taken.
I also think AMRN knows they HAVE TO partner for Anchor or stock price will be even worse. Problem is BP knows this also so will be interesting how many parties they can get involved to maximize the partnership deal. I hope they take the best BP partnership offer and don't hold a high premium and thus go another route.